Different Effects of the Different Natural CC Chemokine Receptor 2b Ligands on β-Arrestin Recruitment, Gαi Signaling, and Receptor Internalization
Authors:
- Yamina A. BerchicheYBYamina A. Berchiche
- Stéphanie GravelSGStéphanie Gravel
- Marie-Eve PelletierMPMarie-Eve Pelletier
- Geneviève St-OngeGSGeneviève St-Onge
- Nikolaus HevekerNHNikolaus Heveker
- 1 March 2011
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 79 (3) , 488-498
Abstract
The chemokine receptor CCR2, which has been implicated in a variety of inflammatory, autoimmune, and cardiovascular conditions, binds several natural chemokine ligands. Here, we assessed the recruitment of β-arrestin to CCR2 in response to these ligands using bioluminescence resonance energy transfer technology. Compared with CCL2, which was considered as a full agonist, other CCR2 ligands were partial agonists with reduced efficacy and potency. Agonist potencies were not a function of their affinity for CCR2. Efficacy of arrestin recruitment matched that of agonist-induced CCR2 internalization. Although the potency and efficacy rank orders of the ligands in arrestin recruitment were similar to those observed for Gαi1 activation, arrestin recruitment was at least in part resistant to Gαi/o-inactivating pertussis toxin, suggesting partial independence from Gαi/o. The degree of pertussis toxin resistance of arrestin recruitment was different between the chemokines. Moreover, qualitative differences between the arrestin responses to the different ligands were identified in the stability of the response: although CCL7-induced arrestin recruitment had a half-life of less than 15 min, CCL8 and CCL13 induced stable CCR2-arrestin interactions. Finally, the ligands stabilized different conformations of the CCR2 homodimer. Our results support the validity of models for receptor-ligand interactions in which different ligands stabilize different receptor conformations also for endogenous receptor ligands, with corresponding implications for drug development targeting CCR2.Keywords
This publication has 41 references indexed in Scilit:
- β-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7Proceedings of the National Academy of Sciences, 2009
- An arrestin-dependent multi-kinase signaling complex mediates MIP-1β/CCL4 signaling and chemotaxis of primary human macrophagesJournal of Leukocyte Biology, 2009
- AMD3100 Is a CXCR7 Ligand with Allosteric Agonist PropertiesMolecular Pharmacology, 2009
- Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptorsTrends in Pharmacological Sciences, 2007
- Conformational complexity of G-protein-coupled receptorsTrends in Pharmacological Sciences, 2007
- Use of a cAMP BRET Sensor to Characterize a Novel Regulation of cAMP by the Sphingosine 1-Phosphate/G13 PathwayJournal of Biological Chemistry, 2007
- Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitusBiochemical and Biophysical Research Communications, 2006
- Functional aberrant expression of CCR2 receptor on chronically activated NK cells in patients with TAP-2 deficiencyBlood, 2005
- High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cellsCytokine, 2004
- Monocyte Chemoattractant Protein-3 Is a Functional Ligand for CC Chemokine Receptors 1 and 2BJournal of Biological Chemistry, 1995